LSE - Delayed Quote GBp
OptiBiotix Health Plc (OPTI.L)
19.66
-0.84
(-4.10%)
As of 10:10:39 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1.53M
-1.53M
-1.11M
-1.56M
-927.96k
Investing Cash Flow
1.11M
1.11M
-331.00k
2.71M
-350.35k
Financing Cash Flow
0.00
0.00
485.00k
0.00
1.69M
End Cash Position
635.00k
635.00k
1.05M
2.01M
864.68k
Capital Expenditure
--
--
-168.00k
-194.00k
-350.35k
Issuance of Capital Stock
0.00
0.00
485.00k
0.00
940.63k
Issuance of Debt
--
--
--
--
0.00
Free Cash Flow
-1.53M
-1.53M
-1.28M
-1.76M
-1.28M
12/31/2020 - 9/9/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBX.AQ ProBiotix Health Plc
6.51
0.00%
SBTX.L SkinBioTherapeutics plc
21.20
-3.64%
0QAJ.IL DBV Technologies S.A.
1.6900
-2.48%
IMM.L ImmuPharma plc
3.0001
-4.30%
TRX.L Tissue Regenix Group plc
32.12
-1.17%
BVXP.L Bioventix PLC
2,830.00
+0.35%
ALXO ALX Oncology Holdings Inc.
0.5037
-8.42%
CDTX Cidara Therapeutics, Inc.
19.70
-8.40%
TVRD Tvardi Therapeutics, Inc.
26.25
-5.54%
DBVT DBV Technologies S.A.
9.39
+1.51%